Oral Precancers – New Management Options
Accurate assessment of the carcinogenic potential of oral mucosal diseases can significantly reduce the prevalence of oral cancer. During the grand rounds, participants will learn about current management strategies for precancerous oral lesions and discuss new treatment options for oral precancers.
Target Audience
Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, Endocrinologists, Pulmonologists, Otolaryngologists, Urologists, Colorectal Surgeons, Neurologists, General Surgeons, Orthopedic Surgeons, Oral Maxillofacial Surgeons, Breast Surgeons, General Practitioners, Obstetricians and Gynecologists, Patient Navigators, Dentists, Nurses, Advanced Practice Registered Nurses, Social Workers and all other interested healthcare professionals.
Learning Objectives
- Identify the clinical presentation of oral precancers.
- Implement current management strategies for oral precancerous lesions.
- Discuss new treatment options for oral precancers.
Alessandro Villa, DDS, Ph.D., MPH
Oral Medicine Associates, P.A.
Chief of Oral Medicine, Oral Oncology and Dentistry
Professor, Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Alessandro Villa, DDS, Ph.D., faculty for this educational activity, is a consultant for Merck, Lipella Pharmaceuticals and AFYX Therapeutics and a researcher for PCCA. He has indicated that the presentation or discussion will include off-label or unapproved product usage.
Guilherme Rabinowits, M.D., conference director of this educational activity, is a consultant/advisor with Sanofi-Genzyme, Regeneron, Castle Biosciences and Boston Gene.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Clinical Social Workers, Marriage and Family Therapists and Mental Health Counselors
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |